nmible partners with Velocity Clinical Research to streamline clinical trials patient stipends
January 24, 2024 08:05 ET
|
Velocity Clinical Research, Inc.
• nmible’s solution expected to save more than 650 working days per year, administering payments • Velocity spends $20 million a year in patient stipends LONDON, Jan. 24, 2024 (GLOBE NEWSWIRE)...
Velocity Clinical Research transforms patient experience and recruitment with VISION technology platform
January 09, 2024 07:01 ET
|
Velocity Clinical Research, Inc.
• App downloads surpassed 25,000 • First time a clinical trials site business has developed end-to-end system for patients DURHAM, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Velocity Clinical...
Velocity expandiert auf 17 Standorte in Europa
January 04, 2024 03:00 ET
|
Velocity Clinical Research, Inc.
Velocity wird zu einem der größten Netzwerke von Prüfzentren in Europa und ist außerdem das größte in den USA.Erweitert die therapeutischen Möglichkeiten um den Bereich Onkologie LONDON, Jan. 04,...
Velocity expands to 17 sites in Europe
January 03, 2024 03:00 ET
|
Velocity Clinical Research, Inc.
Velocity becomes one of largest site organisations in Europe in addition to being the largest in the U.S.Adds Oncology to therapeutic capability LONDON, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Velocity...
Velocity rozszerza swoją działalność na 17 ośrodków w Europie
January 03, 2024 03:00 ET
|
Velocity Clinical Research, Inc.
Firma Velocity będąca największą w Stanach Zjednoczonych siecią ośrodków badań klinicznych staje się również jedną z największych sieci ośrodków badań klinicznych w Europie.Dodaje onkologię do...
Velocity Clinical Research rozszerza działalność na Polskę
December 06, 2023 06:00 ET
|
Velocity Clinical Research, Inc.
Sieć silnych polskich ośrodków badwczych w planach nabycia do końca 2023 rokuZatrudnienie byłej Globalnej Szefowej ds. Rozwiązań w Ośrodkach Badwczych (Global Head Site Solutions)w firmie Parexel,...
Velocity Clinical Research expands to Poland
December 06, 2023 06:00 ET
|
Velocity Clinical Research, Inc.
Strong pipeline of Polish acquisition targets by end of 2023Hires ex-Parexel Global Head Site Solutions to lead Polish expansion LONDON, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Velocity Clinical Research...
Velocity baut MASH/MASLD-Kapazitäten mit jüngsten Standortübernahmen aggressiv aus
October 26, 2023 05:28 ET
|
Velocity Clinical Research, Inc.
• Gewinnung von zwei Meinungsbildnern: Dr. Kris Kowdley und Dr. Nadege Gunn • Aufbau auf bestehenden MASH/MASLD-Fähigkeiten an 23 Standorten weltweit DURHAM, North Carolina, Oct. 26, 2023 (GLOBE...
Velocity aggressively expands MASH/MASLD capabilities with latest site acquisitions
October 25, 2023 07:04 ET
|
Velocity Clinical Research, Inc.
• Add two KOLs: Dr Kris Kowdley and Dr Nadege Gunn • Builds on existing MASH/MASLD capabilities at 23 sites globally DURHAM N.C., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Velocity Clinical...
Velocity opens three U.K. greenfield clinical research sites
October 04, 2023 04:36 ET
|
Velocity Clinical Research, Inc.
LONDON, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity”), the leading multi-specialty clinical sites business, announced it is opening greenfield clinical research sites in...